Fresenius SE (FREd)
FRA • Healthcare
February 17, 2026 at 16:30 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Fresenius SE is a healthcare company that combines manufacturing, services, and project expertise into a single operating approach. The group supports hospitals and care providers with medicines, clinical nutrition, devices, and technical services that fit routine practice. Business units work to a shared quality system, and documentation is written for regulators, payers, and clinical audit teams. Geographic reach spans mature health systems and emerging markets through regional subsidiaries that use the same core rules. Procurement and validation are handled as everyday disciplines rather than one-off campaigns. The company positions itself within the healthcare ecosystem as a partner that keeps therapies and services available while respecting clinical governance. Program cadence favors clear steps from evidence to labeling and from setup to steady care.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Fresenius SE's Technical Indicators Summary
FREd’s price action currently reflects a neutral stance, supported by modest trend strength as indicated by an ADX around 22, suggesting neither strong nor weak directional momentum. Momentum oscillators such as RSI and CCI remain in hold territory, while the MACD level is slightly positive but also neutral, reinforcing the lack of decisive momentum. The price trades below most short and medium-term moving averages, which signal bearish pressure, yet remains above longer-term averages that show some underlying support. Volatility is moderate with an ATR near 2%, and volume indicators like OBV hint at accumulation despite price softness. Meanwhile, the price sits just below the VWAP and key pivot points, which are currently bearish. Overall, the technical profile points to a market in balance without clear directional conviction.
| Indicator | Value |
|---|---|
RSI (14) | 42.67 |
Stochastic %K (14, 3, 3) | 32.72 |
CCI (20) | -67.06 |
WPR (14) | -96.29 |
Momentum (10) | -0.87 |
MFI | 56.35 |
MACD Level (12, 26) | 0.41 |
Bollinger Bands | $46.49 - $51.54 |
ATR (14) | $1.06 (2.23%) |
ADX (14) | 22.09 |
OBV | 47,902,343 |
VWAP | $48.09 |
Classic Pivot Point | $49.22 |
Fibonacci Pivot Point | $49.22 |
Simple Moving Averages | $45.12 - $49.83(5 indicators) |
Exponential Moving Averages | $44.90 - $49.37(5 indicators) |
Get premium market insights delivered directly to your inbox.
The session ended with FREd modestly above yesterday’s 51.12, maintaining its 1.682% gap and finishing at 51.98. End-of-day, the peer group was roughly unchanged (-0.23%), limiting broader influence on FREd. FREd's slight rise is driven by its stable session amid limited broader sector influence and no recent news catalysts.
Price Change
from €51.12 close
+€0.86
Trading Volume
Below avg (603.5K)
244.4K
vs S&P 500 Today
Outperforming Market
+1.60%
52-Week Position
Near highs
99.6%
Updated: February 17, 2026 at 16:06 UTC